Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
Wang Liao, Jiaxin Xu, Bo Li, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 555
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 184
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 3
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Daniela Dias, Renato Socodato
Biomedicines (2025) Vol. 13, Iss. 2, pp. 279-279
Open Access | Times Cited: 2
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 68
Metformin role in Parkinson’s disease: a double-sword effect
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 41
Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Mingyang Sun, Wan‐Ming Chen, Szu‐Yuan Wu, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1474-1482
Closed Access | Times Cited: 23
Unraveling the intercellular communication disruption and key pathways in Alzheimer’s disease: an integrative study of single-nucleus transcriptomes and genetic association
Andi Liu, Brisa S. Fernandes, Citu Citu, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Circular RNAs in human diseases
Yuanyong Wang, Jin Zhang, Yu‐Chen S. H. Yang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 9
How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies
Stacey M. Fernandes, Johanna Mayer, Per Nilsson, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Comparative efficacy and safety of antidiabetic agents in Alzheimer's disease: A network meta-analysis of randomized controlled trials
Zixin Cai, Jiaxin Zhong, Guanghui Zhu, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100111-100111
Open Access | Times Cited: 1
Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease
Darius J.R. Lane, Francesca M. Alves, Scott Ayton, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 141-161
Closed Access | Times Cited: 20
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 20
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 18
Unveiling the Enigma: Exploring Risk Factors and Mechanisms for Psychotic Symptoms in Alzheimer’s Disease through Electronic Medical Records with Deep Learning Models
Peihao Fan, Oshin Miranda, Xiguang Qi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 911-911
Open Access | Times Cited: 16
Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation
Mahmoud Khaleghi-Mehr, Alireza-Azizzadeh Delshad, Sepideh Shafie-Damavandi, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1127-1142
Closed Access | Times Cited: 15
Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
Lidan Hu, Wenmin Wang, Xiangjun Chen, et al.
Brain‐X (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Novel targets and therapies of metformin in dementia: old drug, new insights
Wenxing Cui, Chen Lv, Panling Geng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records
William T. Doran, Louis Tunnicliffe, Rutendo Muzambi, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 1, pp. e003548-e003548
Open Access | Times Cited: 4
Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study
George Jîtcă, Zsolt Gáll, Carmen-Maria Jîtcă, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 403-403
Open Access | Times Cited: 4
Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer’s Disease: An Educational Literature Review
Mostafa Hossam El Din Moawad, Ibrahim Serag, Ibraheem M. Alkhawaldeh, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 4
Emerging role of adaptive immunity in diabetes-induced cognitive impairment: from the periphery to the brain
Genhui Yang, Ruibing Su, Jie Bu, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Functional connectivity across multi-frequency bands in patients with tension-type headache: a resting-state fMRI retrospective study
Jili Wang, Hongjie Shen, Qinyan Xu, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Diabetes Mellitus and Energy Dysmetabolism in Alzheimer’s Disease: Understanding the Relationships and Potential Therapeutic Targets
Adejoke Y. Onaolapo, Folusho O. Ojo, Olufunto O. Adeleye, et al.
Current Diabetes Reviews (2023) Vol. 19, Iss. 8
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top